Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2020

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Positive Preclinical Data for Potential Anxiety Treatment

VTGN CEO “even more excited about PH94B’s potential to change lives without the risky side effects and safety concerns of benzos” Study results suggest PH94B’s mechanism of action may not have benzodiazepine-like side effects, such as sedation, cognitive impairment or … Continue reading

Posted in VistaGen Therapeutics Inc. VTGN | Leave a comment

As World Transitions away from Gas Guzzlers, Net Element Inc. (NASDAQ: NETE) Entering EV Market Through Mullen Technologies Merger

NETE plans to divest payments processing model to enter EV industry through proposed merger with privately-held Mullen Technologies Inc. Merger allows Mullen stakeholders to obtain majority of stock while accelerating process of taking company public, funding US expansion Mullen accepting … Continue reading

Posted in Net Element Inc. NETE | Leave a comment

MissionIRNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Featured in SNN Network Interview

Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced that it was featured in a new video interview with SNN Network, “The Official Small-, Micro- and Nano-Cap News Source(TM).” According to the … Continue reading

Posted in Jupiter Wellness Inc. JUPW | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Advancement of MS1819 Combination Therapy Trial in Turkey

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that the first two patients have been dosed in Turkey for its Phase 2 trial. The trial evaluates its investigational drug, MS1819, … Continue reading

Posted in AzurRx BioPharma Inc. AZRX | Leave a comment

MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) to Begin Trading Under Nasdaq Ticker Symbol “WRAP”

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced that its Nasdaq ticker symbol is set to change from “WRTC” to “WRAP” beginning at market open on Tuesday, December 1, 2020. “We are excited to align the … Continue reading

Posted in Wrap Technologies Inc. WRTC | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Platform Meets Today’s Demands Through Intelligent Design

Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health care platform, is ideally situated as the global pandemic has led to a cascade of changes involving how health care is administered, perhaps most notably in the increased adoption of … Continue reading

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Provide Digital Therapeutics Solution to Employees of Fortune 500 Company

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be providing its digital therapeutics solution to qualified employees of a U.S.-based Fortune 500 technology company. The contract, which goes into effect on Jan. 1, 2021, with the … Continue reading

Posted in DarioHealth Corp. DRIO | Leave a comment

Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Sells 15 Streamway(R) Systems in Q3 2020 as COVID-era Drives Need for Sanitation Systems

Closed design of Streamway(R) System provides safety from potential hazards of drips and spills during endoscopy, radiology, cystoscopy, urology procedures The Streamway(R) System reduces costs, minimizes environmental impact of 50 million potentially disease-infected canisters disposed into landfills POAI’s Skyline Medical … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

AzurRx BioPharma Inc. (NASDAQ: AZRX) Planning to Test Immediate Release MS1819 Capsules in Cystic Fibrosis Study

The company plans to add another study arm to its ongoing Phase 2b OPTION 2 clinical study which currently tests delayed release capsules If it receives FDA approval, AzurRx would be able to identify the optimal delivery method for its … Continue reading

Posted in AzurRx BioPharma Inc. AZRX | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) IND Application for Cancer Drug Berubicin Accepted for Review

CNS Pharmaceuticals wants to obtain FDA authorization for an Investigational New Drug application for drug candidate Berubicin, a novel treatment for Glioblastoma Multiforme Company believes it’s on track to start in Q1 2021 a potentially pivotal Phase II Berubicin trial … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment